Europe — EMA
Onkotrone Injection (Mitoxantrone)
Mitoxantrone, the active ingredient in Onkotrone Injection, is an anthracycline antineoplastic agent presented as a injection for intravenous use.
Request sourcing
What is Mitoxantrone?
Mitoxantrone, the active ingredient in Onkotrone Injection, is an anthracycline antineoplastic agent presented as a injection for intravenous use. It treats certain types of cancer and is used in adult oncology patients. GNH USA supplies Onkotrone Injection as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
GNH USA supplies Onkotrone Injection as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
What is Mitoxantrone used for?
Mitoxantrone is an antineoplastic agent that interferes with DNA synthesis and is employed in several malignancies.
- Acute leukaemia: helps ... ... ... ... ... ... … … … … … … … … … … - Chronic .... .... .... .... .... .... .... .... .... .... .... .... ...
